Skip to main content

Baltimore early cancer detection startup raises $3 million

Previse, previously known as Capsulomics, will use the funding to support a commercial launch of a test of an early detection test for esophageal cancer.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.